Importantly, treatment with the SCD-specific inhibitor MF438 efficiently blocked the CES1 effect on HCC apoptosis, further highlighting the key role of SCD in CES1-mediated cancer cell growth. The gene discussed is CES1; the disease is hepatocellular carcinoma.